In the Clinic Chagas Disease

被引:22
|
作者
Hochberg, Natasha S. [1 ,2 ,3 ]
Montgomery, Susan P. [4 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02215 USA
[2] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA
[3] Boston Med Ctr, Boston, MA 02118 USA
[4] CDCP, Parasit Dis Branch, Atlanta, GA, Georgia
关键词
TRYPANOSOMA-CRUZI INFECTION; RANDOMIZED-TRIAL; UNITED-STATES; TRANSMISSION; BENZNIDAZOLE; RECOMMENDATIONS; TRANSPLANTATION; MANAGEMENT; CONSENSUS; SOCIETY;
D O I
10.7326/AITC202302210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is a leading neglected tropical disease in the United States. An estimated 240 000 to 350 000 persons in the United States are infected, primarily immigrants from Mexico, Central America, and South America, where the disease is endemic. The parasite is transmitted by the triatomine bug but can also be passed through blood transfusion, via organ transplant, or congenitally. Approximately 30% of infected persons later develop cardiac and/or gastrointestinal complications. Health care providers should consider screening at-risk patients with serologic testing. Early diagnosis and treatment with benznidazole or nifurtimox can help prevent complications.
引用
收藏
页码:17 / 32
页数:16
相关论文
共 50 条
  • [11] Chagas disease in Oklahoma
    Higuita, Nelson Ivan Agudelo
    Bronze, Michael S.
    Smith, James W.
    Montgomery, Susan P.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (05) : 521 - 528
  • [12] Chagas Disease in Europe
    Gonzalez-Sanz, Marta
    Crespillo-Andujar, Clara
    Chamorro-Tojeiro, Sandra
    Monge-Maillo, Begona
    Perez-Molina, Jose A.
    Norman, Francesca F.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (12)
  • [13] Congenital Chagas Disease
    Chancey, Rebecca J.
    Edwards, Morven S.
    Montgomery, Susan P.
    PEDIATRICS IN REVIEW, 2023, 44 (04) : 213 - 221
  • [14] Chagas disease in Switzerland: current situation, challenges and opportunities
    Chollet, Vincent
    Rapp, Elise
    Velarde-Rodriguez, Mar
    Gold, Marina
    Maser, Pascal
    Fehr, Jan
    Monnier, Nora
    Jackson, Yves
    Albajar-Vinas, Pedro
    De Salazar, Pablo M.
    SWISS MEDICAL WEEKLY, 2024, 154
  • [15] Clinical and pharmacological profile of benznidazole for treatment of Chagas disease
    Kratz, Jadel Mueller
    Garcia Bournissen, Facundo
    Forsyth, Colin J.
    Sosa-Estani, Sergio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (10) : 943 - 957
  • [16] Chagas disease in Spain, 2012
    Perez-Arellano, J. L.
    REVISTA CLINICA ESPANOLA, 2012, 212 (07): : 344 - 346
  • [17] The senseless orphanage of Chagas disease
    Alonso-Vega, Cristina
    Losada-Galvan, Irene
    Pinazo, Maria-Jesus
    Sancho Mas, Javier
    Gascon Brustenga, Joaquim
    Alonso-Padilla, Julio
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (12): : 535 - 545
  • [18] Benznidazole for the treatment of Chagas disease
    Losada Galvan, Irene
    Alonso-Padilla, Julio
    Cortes-Serra, Nuria
    Alonso-Vega, Cristina
    Gascon, Joaquim
    Jesus Pinazo, Maria
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (05) : 547 - 556
  • [19] The epidemiology of Chagas disease in the Americas
    Cucunuba, Zulma M.
    Gutierrez-Romero, Sebastian A.
    Ramirez, Juan-David
    Velasquez-Ortiz, Natalia
    Ceccarelli, Soledad
    Parra-Henao, Gabriel
    Henao-Martinez, Andres F.
    Rabinovich, Jorge
    Basanez, Maria-Gloria
    Nouvellet, Pierre
    Abad-Franch, Fernando
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 37
  • [20] Chagas disease: comments on the 2018 PAHO Guidelines for diagnosis and management
    Norman, Francesca F.
    Lopez-Velez, Rogelio
    JOURNAL OF TRAVEL MEDICINE, 2019, 26 (07)